Impact of an emergency department-initiated clinical protocol for the evaluation and treatment of atrial fibrillation

Critical Pathways in Cardiology

Volumn 13, Issue 2, 2014, Pages 43-48

  Elmouchi, Darryl A ^a,b   Vanoosterhout, Stacie ^c   Muthusamy, Purushothaman ^d   Khan, Mohsin ^e   Puetz, Cathy ^c   Davis, Alan T ^b,f   Brown, Michael D ^b,c  

^a Frederik Meijer Heart and Vascular Institute   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Department of Research Spectrum Health ^*  (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e Hospitalist Medicine Spectrum Health   (United States)

^f Grand Rapids Medical Education Partners   (United States)

Author keywords

Atrial fibrillation; Clinical pathway; Emergency department

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ARTICLE; CARDIOVERSION; CHADS2 SCORE; CLINICAL PATHWAY; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE DURATION; EMERGENCY WARD; FEMALE; FLUID THERAPY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RESTING HEART RATE; SINUS RHYTHM; THROMBOEMBOLISM; ATRIAL FIBRILLATION; COMPLICATION; CONTROLLED STUDY; DISEASE MANAGEMENT; EMERGENCY HEALTH SERVICE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STROKE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CLINICAL PROTOCOLS; DISEASE MANAGEMENT; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; STROKE;

EID: 84901474782     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0000000000000008     Document Type: Article

References (25)

1. E uropean Heart Rhythm A, European Association for Cardio-Thoracic S, Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12:1360-1420.
2. G o AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
3. L loyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation. 2004;110:1042-1046.
4. C oyne KS, Paramore C, Grandy S, et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006;9:348-356.
5. Wann LS, Curtis AB, Ellenbogen KA, et al. 2011 ACC F/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011;57:1330-1337.
6. G age BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-2870.
7. L ip GY, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med. 2010;123:484-488.
8. A lboni P, Botto GL, Baldi N, et al. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. N Engl J Med. 2004;351:2384-2391.
9. Spertus J, Dorian P, Bubien R, et al. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:15-25.
10. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360-1369.
11. Friberg J, Buch P, Scharling H, et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology. 2003;14:666-672.
12. Stiell IG, Clement CM, Brison RJ, et al. Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments. Ann Emerg Med. 2011;57:13-21.
13. Michael JA, Stiell IG, Agarwal S, et al. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med. 1999;33:379-387.
14. Joseph AP, Ward MR. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med. 2000;36:1-9.
15. I nnes GD, Vertesi L, Dillon EC, et al. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation. Ann Emerg Med. 1997;29:126-134.
16. Stiell IG, Clement CM, Perry JJ, et al. Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter. CJEM. 2010;12:181-191.
17. Scheuermeyer FX, Grafstein E, Stenstrom R, et al. Thirty-day and 1-year outcomes of emergency department patients with atrial fibrillation and no acute underlying medical cause. Ann Emerg Med. 2012;60:755-765. e2.
18. Burton JH, Vinson DR, Drummond K, et al. Electrical cardioversion of emergency department patients with atrial fibrillation. Ann Emerg Med. 2004;44:20-30.
19. Jacoby JL, Cesta M, Heller MB, et al. Synchronized emergency department cardioversion of atrial dysrhythmias saves time, money and resources. J Emerg Med. 2005;28:27-30.
20. Decker WW, Smars PA, Vaidyanathan L, et al. A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation. Ann Emerg Med. 2008;52:322-328.
21. von Besser K, Mills AM. Is discharge to home after emergency department cardioversion safe for the treatment of recent-onset atrial fibrillation? Ann Emerg Med. 2011;58:517-520.
22. Mancini GB, Goldberger AL. Cardioversion of atrial fibrillation: Consideration of embolization, anticoagulation, prophylactic pacemaker, and longterm success. Am Heart J. 1982;104:617-621.
23. Weigner MJ, Caulfield TA, Danias PG, et al. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med. 1997;126:615-620.
24. Fuster V, Rydén LE, Cannom DS, et al.; Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC /AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J. 2006;27:1979-2030.
25. R aghavan AV, Decker WW, Meloy TD. Management of atrial fibrillation in the emergency department. Emerg Med Clin North Am. 2005;23:1127-1139.